SCHEMBL7087919

SCHEMBL7087919

Fc1cccc(-c2ccc3cc[nH]c3c2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.63
GHSR Q92847 1/20 0.49
NPC1 O15118 1/20 0.49
TAAR1 Q96RJ0 2/20 0.47
ESR2 Q92731 1/20 0.47
GPR84 Q9NQS5 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
TNKS2 Q9H2K2 1/20 0.45
APP P05067 1/20 0.44
ENPP2 Q13822 1/20 0.44
CMA1 P23946 1/20 0.44
TYR P14679 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA7 P36544 1/20 0.43
CHRNA10 Q9GZZ6 1/20 0.43
CHRNA9 Q9UGM1 1/20 0.43
BACE1 P56817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL147946 0.83 AHR (0.70) AHRGHSRNPC1GPR84APP
SCHEMBL7088159 0.81 NPC1 (0.67) AHRGHSRNPC1ADORA2AADORA1
SCHEMBL30253604 0.81 NPC1 (0.71) AHRGHSRNPC1ADORA2AADORA1
SCHEMBL443799 0.81 NPC1 (0.71) AHRGHSRNPC1ADORA2AADORA1
SCHEMBL5464497 0.79 BRD4 (0.49) AHRGHSRNPC1ADORA2AADORA1
SCHEMBL5664020 0.79 AHR (0.63) AHRNPC1TAAR1ESR2ADORA2A
SCHEMBL981855 0.79 ADORA2A (0.52) AHRNPC1ADORA2AADORA1CMA1
SCHEMBL5464492 0.79 NPC1 (0.49) AHRGHSRNPC1ADORA2AADORA1
SCHEMBL29361924 0.78 AHR (1.00) AHRGPR84APPENPP2CMA1
SCHEMBL444450 0.78 AHR (1.00) AHRGPR84APPENPP2CMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109575032-A The method of level-one amine guiding building 6- (3- fluorophenyl) indoles simultaneously [1,2-a] quinoxaline 桂林理工大学 2019-04-05 CN claimed
CN-109575032-A The method of level-one amine guiding building 6- (3- fluorophenyl) indoles simultaneously [1,2-a] quinoxaline 桂林理工大学 2019-04-05 CN disclosed
CN-109575032-A The method of level-one amine guiding building 6- (3- fluorophenyl) indoles simultaneously [1,2-a] quinoxaline 桂林理工大学 2019-04-05 CN disclosed
CN-109575032-A The method of level-one amine guiding building 6- (3- fluorophenyl) indoles simultaneously [1,2-a] quinoxaline 桂林理工大学 2019-04-05 CN disclosed
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 AHR 379/4885GHSR 238/4885NPC1 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.